Primary Site >> Liver Cancer

Gene >> FGF1

  • 1986
  • 1993
  • 1996
  • 2006
  • 2010
  • 2012
  • 2013
  • 2014
  • 2017
Ref: Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors.
PMID: 3007499
Ref: Sinusoidal capillarization of human hepatocellular carcinoma: possible promotion by fibroblast growth factor.
PMID: 8388557
Ref: Responsiveness of hepatocytes from dichloroacetic acid or phenobarbital treated mice to growth factors in primary culture.
PMID: 8616822
Ref: Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis.
PMID: 8640940
Ref: An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue.
PMID: 8818692
Ref: Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
PMID: 16929488
Ref: Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
PMID: 20657013
Ref: A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts.
PMID: 22351746
Ref: Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models.
PMID: 22615798
Ref: Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
PMID: 23684136
Ref: Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.
PMID: 23970062
Ref: Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.
PMID: 25091573
Ref: Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan) platform.
PMID: 27663888